Cited by — Efficacy and safety of Romiplostim N01 for grades II to IV cancer therapy induced thrombocytopenia in a real world observational study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Efficacy and safety of Romiplostim N01 for grades II to IV cancer therapy induced thrombocytopenia in a real world observational study.
No admitted local citation edges point to this work yet.
